159 related articles for article (PubMed ID: 19906270)
1. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
Eur J Neurol; 2010 Jan; 17(1):e5. PubMed ID: 19906270
[No Abstract] [Full Text] [Related]
2. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
[TBL] [Abstract][Full Text] [Related]
3. Anti-GAD antibodies and periodic alternating nystagmus.
Tilikete C; Vighetto A; Trouillas P; Honnorat J
Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar ataxia and nystagmus with GAD antibodies in a woman from the West Indies : a video demonstration.
Ramcharan K; Reyes AJ; Abdool K; Raamkaransingh N
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31615777
[No Abstract] [Full Text] [Related]
5. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
[No Abstract] [Full Text] [Related]
8. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
[TBL] [Abstract][Full Text] [Related]
9. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
[No Abstract] [Full Text] [Related]
10. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune cerebellar ataxia].
Nanri K; Okuma M; Sato S; Taguchi T; Tanaka N
Nihon Rinsho; 2015 Sep; 73 Suppl 7():632-7. PubMed ID: 26480769
[No Abstract] [Full Text] [Related]
12. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
[No Abstract] [Full Text] [Related]
13. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies in epilepsy and seizure-associated disorders.
McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.
Piccolo G; Tavazzi E; Cavallaro T; Romani A; Scelsi R; Martino G
J Neurol Sci; 2010 Mar; 290(1-2):148-9. PubMed ID: 20056249
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
Georgieva Z; Parton M
BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
[TBL] [Abstract][Full Text] [Related]
19. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
20. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
Ferraz HB
Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
